Literature DB >> 25553704

Review: phage therapy: a modern tool to control bacterial infections.

Muhammad Imran Qadir1.   

Abstract

The evolution of antibiotic-resistant in bacteria has aggravated curiosity in development of alternative therapy to conventional drugs. One of the emerging drugs that can be used alternative to antibiotics is bacteriophage therapy. The use of living phages in the cure of lethal infectious life threatening diseases caused by Gram positive and Gram negative bacteria has been reported. Another development in the field of bacteriophage therapy is the use of genetically modified and non replicating phages in the treatment of bacterial infection. Genetically engineered bacteriophages can be used as adjuvant along with antibiotic therapy. Phages encoded with lysosomal enzymes are also effectual in the treatment of infectious diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25553704

Source DB:  PubMed          Journal:  Pak J Pharm Sci        ISSN: 1011-601X            Impact factor:   0.684


  8 in total

Review 1.  Biological challenges of phage therapy and proposed solutions: a literature review.

Authors:  Katherine M Caflisch; Gina A Suh; Robin Patel
Journal:  Expert Rev Anti Infect Ther       Date:  2019-12-02       Impact factor: 5.091

2.  Prophage lysin Ply30 protects mice from Streptococcus suis and Streptococcus equi subsp. zooepidemicus infections.

Authors:  Fang Tang; Dezhi Li; Haojin Wang; Zhe Ma; Chengping Lu; Jianjun Dai
Journal:  Appl Environ Microbiol       Date:  2015-08-07       Impact factor: 4.792

Review 3.  Current concepts in the pathogenesis and treatment of chronic suppurative otitis media.

Authors:  Rahul Mittal; Christopher V Lisi; Robert Gerring; Jeenu Mittal; Kalai Mathee; Giri Narasimhan; Rajeev K Azad; Qi Yao; M'hamed Grati; Denise Yan; Adrien A Eshraghi; Simon I Angeli; Fred F Telischi; Xue-Zhong Liu
Journal:  J Med Microbiol       Date:  2015-08-05       Impact factor: 2.472

4.  Bacteriophage ZCKP1: A Potential Treatment for Klebsiella pneumoniae Isolated From Diabetic Foot Patients.

Authors:  Omar A Taha; Phillippa L Connerton; Ian F Connerton; Ayman El-Shibiny
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

Review 5.  Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.

Authors:  Zhigang Ju; Wei Sun
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  High Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in Cyprus.

Authors:  Leon Cantas; Kaya Suer; Emrah Guler; Turgut Imir
Journal:  Front Microbiol       Date:  2016-01-13       Impact factor: 5.640

7.  Distribution and drug resistance of pathogenic bacteria in emergency patients.

Authors:  Wei Huai; Qing-Bian Ma; Jia-Jia Zheng; Yang Zhao; Qiang-Rong Zhai
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

Review 8.  Benefaction of probiotics for human health: A review.

Authors:  Rout George Kerry; Jayanta Kumar Patra; Sushanto Gouda; Yooheon Park; Han-Seung Shin; Gitishree Das
Journal:  J Food Drug Anal       Date:  2018-02-02       Impact factor: 6.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.